Nectar Lifesciences Limited
NSE:NECLIFE.NS
39.69 (INR) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2015 Q4 | 2015 Q3 | 2014 Q4 | 2014 Q3 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 3,592.997 | 4,413.743 | 4,521.711 | 3,979.571 | 3,941.163 | 3,878.931 | 3,441.194 | 3,886.404 | 4,030.166 | 4,762.266 | 4,429.95 | 3,645.633 | 3,850.471 | 3,494.875 | 3,773.952 | 4,267.897 | 3,896.246 | 5,647.331 | 6,479.613 | 5,783.525 | 5,753.321 | 7,956.313 | 7,326.041 | 7,238.633 | 5,307.66 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 2,767.892 | 3,465.664 | 3,643.595 | 2,877.872 | 2,791.675 | 2,906.175 | 2,704.063 | 3,086.462 | 2,896.086 | 4,959.397 | 3,250.46 | 2,641.042 | 2,844.151 | 3,715.481 | 2,783.778 | 3,295.589 | 3,062.422 | 5,772.58 | 5,220.985 | 4,551.205 | 4,430.827 | 7,941.836 | 5,879.913 | 5,862.789 | 4,023.612 | 0 | 0 | 0 | 0 |
Gross Profit
| 825.105 | 948.079 | 878.116 | 1,101.699 | 1,149.488 | 972.756 | 737.131 | 799.942 | 1,134.08 | -197.131 | 1,179.49 | 1,004.591 | 1,006.32 | -220.606 | 990.174 | 972.308 | 833.824 | -125.249 | 1,258.628 | 1,232.32 | 1,322.494 | 14.477 | 1,446.128 | 1,375.844 | 1,284.048 | 0 | 0 | 0 | 0 |
Gross Profit Ratio
| 0.23 | 0.215 | 0.194 | 0.277 | 0.292 | 0.251 | 0.214 | 0.206 | 0.281 | -0.041 | 0.266 | 0.276 | 0.261 | -0.063 | 0.262 | 0.228 | 0.214 | -0.022 | 0.194 | 0.213 | 0.23 | 0.002 | 0.197 | 0.19 | 0.242 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 26.54 | 0 | 0 | 0 | 30.7 | 0 | 0 | 0 | 24.35 | 0 | 0 | 0 | 24.46 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 581.674 | 610.043 | 609.948 | 630.021 | 187.962 | 597.858 | 525.63 | 683.308 | 529.223 | 578.482 | 520.922 | 557.768 | 468.964 | 595.702 | 202.929 | 185.246 | 175.045 | 201.614 | 213.708 | 213.184 | 199.654 | 187.378 | 208.365 | 215.727 | 200.58 | 0 | 0 | 0 | 0 |
Other Expenses
| 5.508 | 14.684 | 4.802 | 106.083 | 4.731 | 179.248 | 132.398 | 107.103 | 3.644 | 5.205 | 5.296 | 50.973 | 51.456 | 10.189 | 6.553 | 5.3 | 5.179 | -29.137 | 5.771 | 11.888 | 21.278 | -587.009 | 15.336 | 14.496 | 13.097 | 0 | 0 | 0 | 0 |
Operating Expenses
| 581.674 | 610.043 | 609.948 | 986.175 | 947.41 | 940.677 | 870.508 | 1,021.837 | 862.947 | -546.087 | 856.379 | 871.558 | 795.43 | -485.268 | 813.609 | 808.524 | 817.775 | -514.21 | 850.989 | 891.502 | 866.599 | -587.009 | 962.338 | 887.522 | 845.409 | 0 | 0 | 0 | 0 |
Operating Income
| 243.431 | 338.036 | 268.168 | 221.607 | 202.078 | 211.327 | -0.979 | -114.799 | 271.133 | 348.943 | 323.111 | 133.033 | 210.89 | 264.662 | 176.565 | 163.784 | 16.049 | 388.961 | 407.639 | 340.818 | 455.895 | 601.486 | 483.79 | 488.322 | 438.639 | 0 | 0 | 0 | 0 |
Operating Income Ratio
| 0.068 | 0.077 | 0.059 | 0.056 | 0.051 | 0.054 | -0 | -0.03 | 0.067 | 0.073 | 0.073 | 0.036 | 0.055 | 0.076 | 0.047 | 0.038 | 0.004 | 0.069 | 0.063 | 0.059 | 0.079 | 0.076 | 0.066 | 0.067 | 0.083 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| -194.26 | -226.911 | -243.603 | -205.192 | -171.494 | -196.691 | -174.638 | -209.93 | -210.023 | -169.107 | -170.945 | -129.121 | -205.999 | -621.881 | -299.79 | -273.535 | -273.524 | -305.249 | -304.976 | -314.959 | -293.419 | -372.218 | -344.641 | -421.039 | -286.139 | 0 | 0 | 0 | 0 |
Income Before Tax
| 49.171 | 111.125 | 24.565 | 16.415 | 30.584 | 14.636 | -175.617 | -324.729 | 61.11 | 179.831 | 152.166 | 3.912 | 4.891 | -357.219 | -123.225 | -109.751 | -257.475 | 83.712 | 102.663 | 25.859 | 162.476 | 229.268 | 139.149 | 67.283 | 152.5 | 0 | 0 | 0 | 0 |
Income Before Tax Ratio
| 0.014 | 0.025 | 0.005 | 0.004 | 0.008 | 0.004 | -0.051 | -0.084 | 0.015 | 0.038 | 0.034 | 0.001 | 0.001 | -0.102 | -0.033 | -0.026 | -0.066 | 0.015 | 0.016 | 0.004 | 0.028 | 0.029 | 0.019 | 0.009 | 0.029 | 0 | 0 | 0 | 0 |
Income Tax Expense
| 19.48 | 105.205 | 8.896 | 6.262 | 12.38 | -21.738 | -82.738 | -100.011 | 22.116 | 63.238 | 54.852 | -14.701 | -13.049 | 52.52 | -42.514 | -36.61 | -88.436 | 9.518 | 20.489 | 1.355 | 25.458 | 54.207 | 30.088 | 8.237 | 19.668 | 0 | 0 | 0 | 0 |
Net Income
| 29.691 | 5.924 | 15.669 | 10.153 | 18.204 | 36.373 | -92.879 | -224.718 | 38.994 | 116.603 | 97.314 | 18.613 | 17.94 | -409.749 | -80.711 | -73.141 | -169.039 | 74.194 | 82.174 | 24.504 | 137.018 | 175.061 | 109.061 | 59.046 | 132.832 | 0 | 0 | 0 | 0 |
Net Income Ratio
| 0.008 | 0.001 | 0.003 | 0.003 | 0.005 | 0.009 | -0.027 | -0.058 | 0.01 | 0.024 | 0.022 | 0.005 | 0.005 | -0.117 | -0.021 | -0.017 | -0.043 | 0.013 | 0.013 | 0.004 | 0.024 | 0.022 | 0.015 | 0.008 | 0.025 | 0 | 0 | 0 | 0 |
EPS
| 0.13 | 0.03 | 0.07 | 0.045 | 0.081 | 0.16 | -0.41 | -1 | 0.17 | 0.52 | 0.43 | 0.08 | 0.08 | -1.83 | -0.36 | -0.33 | -0.75 | 0.33 | 0.37 | 0.11 | 0.61 | 0.79 | 0.49 | 0.26 | 0.59 | 0.32 | 0.78 | 0.74 | 0.75 |
EPS Diluted
| 0.13 | 0.03 | 0.07 | 0.045 | 0.081 | 0.16 | -0.41 | -1 | 0.17 | 0.52 | 0.43 | 0.08 | 0.08 | -1.83 | -0.36 | -0.33 | -0.75 | 0.33 | 0.37 | 0.11 | 0.61 | 0.79 | 0.49 | 0.26 | 0.59 | 0.32 | 0.73 | 0.74 | 0.75 |
EBITDA
| 398.034 | 485.037 | 421.903 | 374.73 | 360.134 | 359.813 | 146.859 | 33.114 | 421.729 | 313.957 | 471.19 | 325.547 | 405.126 | -213.372 | 334.132 | 320.012 | 171.738 | 200.258 | 565.688 | 490.436 | 641.208 | 160.431 | 667.902 | 658.27 | 614.667 | 0 | 0 | 0 | 0 |
EBITDA Ratio
| 0.111 | 0.11 | 0.093 | 0.094 | 0.091 | 0.093 | 0.043 | 0.009 | 0.105 | 0.066 | 0.106 | 0.089 | 0.105 | -0.061 | 0.089 | 0.075 | 0.044 | 0.035 | 0.087 | 0.085 | 0.111 | 0.02 | 0.091 | 0.091 | 0.116 | 0 | 0 | 0 | 0 |